Skip to main content
. 2020 Mar 11;2020:7126976. doi: 10.1155/2020/7126976

Figure 4.

Figure 4

Relative mRNA levels of miR-338-5p. (a) The effects of chidamide on the level of miR-338-5p in U87 cells. (b) The effects of chidamide on the level of miR-338-5p in HS683 cells. (c) Relative mRNA levels of miR-338-5p in U87 glioma cells. (d) Relative mRNA levels of miR-338-5p in HS683 glioma cells. CG: control group; CHG: chidamide group; MG: miR-338-5p mimic group; IG: miR-338-5p inhibitor group; CHMG: chidamide-treated miR-338-5p mimic group; CHIG: chidamide-treated miR-338-5p inhibitor group. N = 5 for each group and ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 vs. the CG group.